-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professional reading reference only
Come and check in to learn the wonderful case!
Patient, male, 70 years old
Answer
Click on the space below for the answer
Discussion results:
Imaging evaluation On November 15, 2017, radical total gastrectomy with esophagojejunostomy Roux-en-Y anastomosis + complex adhesion release
2-5 years, review every 6 months;
Review every 1 year for more than 5 years;
Why did this patient choose neoadjuvant therapy?
Click on the space below for the answer
Neoadjuvant therapy/translational therapy: For locally advanced gastric cancer without distant metastasis, the treatment (chemotherapy or chemoradiotherapy) performed before surgery is called neoadjuvant therapy; for patients with distant metastasis, intraperitoneal implantation is included /distant organ metastasis/distant lymph node metastasis, chemotherapy or radiochemotherapy performed in order to have the opportunity to do R0 surgery is called conversion therapy